Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,077 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Functional assessment of intermediate coronary artery stenosis with 4-Fr catheters.
Nogi K, Soeda T, Hara M, Iwama H, Toyokawa N, Sakai S, Yano H, Iwai A, Hashimoto Y, Fujimoto H, Suzuki M, Nakai T, Doi N, Saito Y. Nogi K, et al. Among authors: fujimoto h. Heart Vessels. 2021 May;36(5):638-645. doi: 10.1007/s00380-020-01746-2. Epub 2021 Jan 2. Heart Vessels. 2021. PMID: 33389064
Long-term prognosis of patients undergoing radiofrequency catheter ablation for atrial fibrillation: comparison between heart failure subtypes based on left ventricular ejection fraction.
Fujimoto H, Doi N, Okayama S, Naito M, Kobori A, Kaitani K, Inoue K, Kurotobi T, Morishima I, Yamaji H, Matsui Y, Nakazawa Y, Kusano K, Hirai K, Nakai T, Suzuki M, Yano H, Sakai S, Kimura T, Shizuta S, Saito Y; KPAF investigators. Fujimoto H, et al. Europace. 2022 Apr 5;24(4):576-586. doi: 10.1093/europace/euab201. Europace. 2022. PMID: 34463733
Adenosine triphosphate-guided pulmonary vein isolation for atrial fibrillation: the UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) trial.
Kobori A, Shizuta S, Inoue K, Kaitani K, Morimoto T, Nakazawa Y, Ozawa T, Kurotobi T, Morishima I, Miura F, Watanabe T, Masuda M, Naito M, Fujimoto H, Nishida T, Furukawa Y, Shirayama T, Tanaka M, Okajima K, Yao T, Egami Y, Satomi K, Noda T, Miyamoto K, Haruna T, Kawaji T, Yoshizawa T, Toyota T, Yahata M, Nakai K, Sugiyama H, Higashi Y, Ito M, Horie M, Kusano KF, Shimizu W, Kamakura S, Kimura T; UNDER-ATP Trial Investigators. Kobori A, et al. Among authors: fujimoto h. Eur Heart J. 2015 Dec 7;36(46):3276-87. doi: 10.1093/eurheartj/ehv457. Epub 2015 Aug 30. Eur Heart J. 2015. PMID: 26321237 Clinical Trial.
Efficacy of Antiarrhythmic Drugs Short-Term Use After Catheter Ablation for Atrial Fibrillation (EAST-AF) trial.
Kaitani K, Inoue K, Kobori A, Nakazawa Y, Ozawa T, Kurotobi T, Morishima I, Miura F, Watanabe T, Masuda M, Naito M, Fujimoto H, Nishida T, Furukawa Y, Shirayama T, Tanaka M, Okajima K, Yao T, Egami Y, Satomi K, Noda T, Miyamoto K, Haruna T, Kawaji T, Yoshizawa T, Toyota T, Yahata M, Nakai K, Sugiyama H, Higashi Y, Ito M, Horie M, Kusano KF, Shimizu W, Kamakura S, Morimoto T, Kimura T, Shizuta S; EAST-AF Trial Investigators. Kaitani K, et al. Among authors: fujimoto h. Eur Heart J. 2016 Feb 14;37(7):610-8. doi: 10.1093/eurheartj/ehv501. Epub 2015 Sep 28. Eur Heart J. 2016. PMID: 26417061 Clinical Trial.
The association between late-phase early recurrence within the blanking period after atrial fibrillation catheter ablation and long-term recurrence: Insights from a large-scale multicenter study.
Onishi N, Kaitani K, Nakagawa Y, Inoue K, Kobori A, Nakazawa Y, Ozawa T, Kurotobi T, Morishima I, Miura F, Watanabe T, Masuda M, Naito M, Fujimoto H, Nishida T, Furukawa Y, Shirayama T, Tanaka M, Okajima K, Yao T, Egami Y, Satomi K, Noda T, Miyamoto K, Haruna T, Higashi Y, Ito M, Horie M, Kusano KF, Shimizu W, Kamakura S, Shimizu Y, Hanazawa K, Tamura T, Izumi C, Morimoto T, Kimura T, Shizuta S; EAST-AF Investigators. Onishi N, et al. Among authors: fujimoto h. Int J Cardiol. 2021 Oct 15;341:39-45. doi: 10.1016/j.ijcard.2021.07.053. Epub 2021 Jul 31. Int J Cardiol. 2021. PMID: 34343532
1,077 results